A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Clinical trial NCT01378871 · TERMINATED
Trial details
- NCT number
- NCT01378871
- Sponsor
- Amit Verma
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-01-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.